Edition:
United States

ScinoPharm Taiwan Ltd (1789.TW)

1789.TW on Taiwan Stock Exchange

35.00TWD
17 Nov 2017
Change (% chg)

NT$-0.15 (-0.43%)
Prev Close
NT$35.15
Open
NT$35.40
Day's High
NT$35.60
Day's Low
NT$35.00
Volume
1,113
Avg. Vol
1,497,584
52-wk High
NT$45.19
52-wk Low
NT$32.35

Chart for

About

ScinoPharm Taiwan, Ltd. is a Taiwan-based company principally engaged in the research and development, manufacture and distribution of bulk drugs. The Company's products include anastrozole, galantamine hydrobromide, azacitidine, gemcitabine hydrochloride, benazepril hydrochloride, granisetron hydrochloride, bimatoprost,... (more)

Overall

Beta: 0.16
Market Cap(Mil.): NT$27,794.48
Shares Outstanding(Mil.): 790.74
Dividend: 0.29
Yield (%): 0.82

Financials

  Industry Sector
P/E (TTM): -- 31.18 15.80
EPS (TTM): -- -- --
ROI: -- 15.02 12.07
ROE: -- 16.37 16.02

BRIEF-ScinoPharm Taiwan elects new chairman

* Says the board elects Lo Chih-Hsien as new chairman, effective since Aug. 18

Aug 18 2017

BRIEF-ScinoPharm Taiwan announces decease of chairman

* Says it ZHENG GAO HUI, chairman of the board of the company, passed away on Aug. 14

Aug 14 2017

BRIEF-ScinoPharm Taiwan to pay 2016 dividend on Sept. 15

* Says it will pay dividend for 2016 to shareholders on Sept. 15

Jul 18 2017

Earnings vs. Estimates